UCB Pharma (VOGALENE And VOGALIB) General Information
Two medicinal products. The portfolio comprises of development, manufacturing, marketing and sale of Vogalib(R) and Vogalene(R) medicines. They are approved for use in the symptomatic treatment of nausea and vomiting. The injectible is approved for the prevention of nausea and vomiting in patients under chemotherapy.